Data from Overlaid transcriptome and proteome analyses identify mitotic kinesins as important targets of arylsulfonamide-mediated RBM39 degradation
2024 · 0 citations
https://doi.org/10.1158/1541-7786.c.6672895.v4
P
Pedro Mota
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
117
Papers
113
Citations
4
h-index
3
i10-index
Pedro Mota is an academic researcher. The author has contributed to research in topics: Mitochondrial Function and Pathology & Genetics and Neurodevelopmental Disorders & Epigenetics and DNA Methylation. The author has an h-index of 4, co-authored 100 publications.
ORCID: 0000-0002-7874-2974Papers by this author
worksSupplementary Figure S2 from Overlaid transcriptome and proteome analyses identify mitotic kinesins as important targets of arylsulfonamide-mediated RBM39 degradation
2024 · 0 citations
https://doi.org/10.1158/1541-7786.27034774
Supplementary Figure S1 from Overlaid transcriptome and proteome analyses identify mitotic kinesins as important targets of arylsulfonamide-mediated RBM39 degradation
2024 · 0 citations
https://doi.org/10.1158/1541-7786.27034777
Supplementary Data from Overlaid transcriptome and proteome analyses identify mitotic kinesins as important targets of arylsulfonamide-mediated RBM39 degradation
2024 · 0 citations
https://doi.org/10.1158/1541-7786.27034786
Supplementary Data Table 2 from Overlaid transcriptome and proteome analyses identify mitotic kinesins as important targets of arylsulfonamide-mediated RBM39 degradation
2024 · 0 citations
https://doi.org/10.1158/1541-7786.27034789
Supplementary Figure S7 from Overlaid transcriptome and proteome analyses identify mitotic kinesins as important targets of arylsulfonamide-mediated RBM39 degradation
2024 · 0 citations
https://doi.org/10.1158/1541-7786.27034759
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat